iShares iBonds Dec 2028 Term Corporate ETFIBDT
Type
ETF
Peer group
Taxable bond
Net assets
$3.8B
Expense ratio
0.10%
1-year return
+3.2%
3 years, a year
+5.7%
5 years, a year
+1.2%
12-month yield
4.54%
Holdings
722
What it aims to do.
The iShares iBonds Dec 2028 Term Corporate ETF (the Fund ) seeks to track the investment results of an index composed of U.S. dollar-denominated, investment-grade corporate bonds maturing in 2028.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| BlackRock Funds III | 3.46% |
| CVS Cvs Health Corp | 0.89% |
| Pfizer Investment Enter | 0.70% |
| AMGN Amgen Inc | 0.69% |
| CI Cigna Group/The | 0.67% |
| Aercap Ireland Cap/Globa | 0.64% |
| Blackrock Cash Funds Treasury Sl Agency Shares | 0.60% |
| CRM Salesforce Inc | 0.55% |
| Rtx Corp | 0.54% |
| Morgan Stanley | 0.54% |
More on IBDT.
- IBDT overview
- IBDT holdings
- IBDT risk
- IBDT costs
- IBDT money in and out
- IBDT share classes
- Compare IBDT with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.